Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Filovirus Infections”

Showing 11 of 0 results

Early research (Phase 1)Study completedNCT00646152
What this trial is testing

Poly-ICLC to Prevent Respiratory Viral Infections A Safety Study

Who this might be right for
InfluenzaSevere Acute Respiratory Distress SyndromeSmallpox+2 more
National Institute of Allergy and Infectious Diseases (NIAID) 57
Early research (Phase 1)Study completedNCT02370589
What this trial is testing

Study to Evaluate the Immunogenicity and Safety of an Ebola Virus (EBOV) Glycoprotein (GP) Vaccine in Healthy Subjects

Who this might be right for
Ebola
Novavax 230
Large-scale testing (Phase 3)Not Yet RecruitingNCT07842107
What this trial is testing

Phase 2/3 Trial of Vaccines Against Bundibugyo Virus Disease in Contacts of Cases in DRC

Who this might be right for
Ebola Hemorrhagic FeverBundibugyo Virus Disease
Jean-Pierre Van geertruyden 3,810
Post-approval studies (Phase 4)Active Not RecruitingNCT05992480
What this trial is testing

REVIVE (Response to the Ebola Virus Vaccine)

Who this might be right for
Ebola Virus Disease
Tulane University 40
Early research (Phase 1)Ended earlyNCT02295501
What this trial is testing

A Prospective, Open Label, Phase 1 Safety Study of Passive Immune Therapy During Acute Ebola Virus Disease Using Transfusion of INTERCEPT Plasma Prepared From Volunteer Donors Who Have Recovered From Ebola Virus Disease

Who this might be right for
Acute Ebola Virus Disease
Cerus Corporation 6
Not applicableStudy completedNCT03820739
What this trial is testing

EBOVAC-Salone Extension

Who this might be right for
Ebola Virus Disease
London School of Hygiene and Tropical Medicine 653
Large-scale testing (Phase 3)Study completedNCT02342171
What this trial is testing

Emergency Evaluation of Convalescent Plasma for Ebola Viral Disease (EVD) in Guinea

Who this might be right for
Hemorrhagic Fever, Ebola
Institute of Tropical Medicine, Belgium 606
Not applicableStudy completedNCT03098862
What this trial is testing

PREVAIL VI: Identification of Host Genetic Factors Underlying Ebola Virus Disease Risk, Mortality, Long-term Sequelae, Viral RNA Persistence, Humoral Immunity, and Ebola Vaccine Response

Who this might be right for
Ebola Virus Disease
National Institute of Allergy and Infectious Diseases (NIAID) 4,830
Early research (Phase 1)Study completedNCT02485912
What this trial is testing

Evaluation of a New Ebola Vaccine Using a Short-interval Prime-boost Vaccination

Who this might be right for
Ebola Virus Disease
University of Oxford 40
Early research (Phase 1)WithdrawnNCT02389192
What this trial is testing

Safety and Pharmacokinetics of a Single ZMappTM Administration in Healthy Adult Volunteers

Who this might be right for
Healthy
National Institute of Allergy and Infectious Diseases (NIAID)
Early research (Phase 1)Study completedNCT02368119
What this trial is testing

Ebola CVD-Mali #2000 (Bivalent) VRC-EBOAdc069-00-vp (cAd3-EBO)

Who this might be right for
Ebola Virus DiseaseHemorrhagic Fever
University of Maryland, Baltimore 60

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation